Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Return on Equity: 2010-2025

Historic Return on Equity for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -6.12%.

  • Lifecore Biomedical's Return on Equity fell 2191.00% to -21.72% in Q2 2025 from the same period last year, while for May 2025 it was -21.72%, marking a year-over-year decrease of 2191.00%. This contributed to the annual value of -6.12% for FY2025, which is 688.00% down from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Return on Equity is -6.12%, which was down 908.46% from 0.76% recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Return on Equity registered a high of 0.76% during FY2024, and its lowest value of -6.12% during FY2025.
  • Its 3-year average for Return on Equity is -2.07%, with a median of -0.85% in 2023.
  • As far as peak fluctuations go, Lifecore Biomedical's Return on Equity skyrocketed by 160bps in 2024, and later crashed by 688bps in 2025.
  • Lifecore Biomedical's Return on Equity (Yearly) stood at -0.05% in 2021, then crashed by 66bps to -0.70% in 2022, then decreased by 14bps to -0.85% in 2023, then spiked by 160bps to 0.76% in 2024, then crashed by 688bps to -6.12% in 2025.